Identification of the Residues in the Extracellular Domain of Thrombopoietin Receptor Involved in the Binding of Thrombopoietin and a Nuclear Distribution Protein (Human NUDC)*

Thrombopoietin (TPO) and its receptor (Mpl) have long been associated with megakaryocyte proliferation, differentiation, and platelet formation. However, studies have also shown that the extracellular domain of Mpl (Mpl-EC) interacts with human (h) NUDC, a protein previously characterized as a human homolog of a fungal nuclear migration protein. This study was undertaken to further delineate the putative binding domain on the Mpl receptor. Using the yeast two-hybrid system assay and co-immunoprecipitation, we identified that within the Mpl-EC domain 1 (Mpl-EC-D1), amino acids 102–251 were strongly involved in ligand binding. We subsequently expressed five subdomains within this region with T7 phage display. Enzyme-linked immunosorbent binding assays identified a short stretch of peptide located between residues 206 and 251 as the minimum binding domain for both TPO and hNUDC. A series of sequential Ala replacement mutations in the region were subsequently used to identify the specific residues most involved in ligand binding. Our results point to two hydrophobic residues, Leu228 and Leu230, as having substantial effects on hNUDC binding. For TPO binding, mutations in residues Asp235 and Leu239 had the largest effect on binding efficacy. In addition, deletion of the conservative motif WGSWS reduced binding capacity for hNUDC but not for TPO. These separate binding sites on the Mpl receptor for TPO and hNUDC raise interesting implications for the cytokine-receptor interactions.

[1]  Qiang Zhang,et al.  Interference RNA (RNAi)-based silencing of endogenous thrombopoietin receptor (Mpl) in Dami cells resulted in decreased hNUDC-mediated megakaryocyte proliferation and differentiation. , 2009, Experimental cell research.

[2]  P. Xu,et al.  hNUDC promotes the cell proliferation and differentiation in a leukemic cell line via activation of the thrombopoietin receptor (Mpl) , 2008, Leukemia.

[3]  Stephen R Comeau,et al.  ClusPro: Performance in CAPRI rounds 6–11 and the new server , 2007, Proteins.

[4]  Yong Tang,et al.  Regulation of cell differentiation by hNUDC via a Mpl-dependent mechanism in NIH 3T3 cells. , 2007, Experimental cell research.

[5]  Yan Yang,et al.  Functional characterization of hNUDC as a novel accumulator that specifically acts on in vitro megakaryocytopoiesis and in vivo platelet production , 2006, Journal of cellular biochemistry.

[6]  Yan Yang,et al.  A microtubule associated protein (hNUDC) binds to the extracellular domain of thrombopoietin receptor (Mpl) , 2005, Journal of cellular biochemistry.

[7]  Takashi Kato,et al.  Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Dennett.  The Self as a Responding—and Responsible—Artifact , 2003, Annals of the New York Academy of Sciences.

[9]  K. Caldwell,et al.  Role for NudC, a dynein-associated nuclear movement protein, in mitosis and cytokinesis , 2003, Journal of Cell Science.

[10]  K. Kaushansky,et al.  The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production , 2002, Oncogene.

[11]  V. Broudy,et al.  Identification and characterization of an isoform of murine Mpl. , 2002, Biochimica et biophysica acta.

[12]  M. Razzaque,et al.  Involvement of the fungal nuclear migration gene nudC human homolog in cell proliferation and mitotic spindle formation. , 2002, Experimental cell research.

[13]  S. Mcconnell,et al.  NudC Associates with Lis1 and the Dynein Motor at the Leading Pole of Neurons , 2001, The Journal of Neuroscience.

[14]  J. Ihle,et al.  Membrane localization is not required for Mpl function in normal hematopoietic cells. , 2001, Blood.

[15]  M. Umemiya,et al.  A Calcium-Dependent Feedback Mechanism Participates in Shaping Single NMDA Miniature EPSCs , 2001, The Journal of Neuroscience.

[16]  F. D. de Sauvage,et al.  Role of the Distal Half of the c-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin In Vivo , 2000, Molecular and Cellular Biology.

[17]  G. Reaman,et al.  The Nuclear Migration Gene Nudc and Human Hematopoiesis , 2000, Leukemia and Lymphoma.

[18]  V. Broudy,et al.  Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding. , 1999, Blood.

[19]  I. Wilson,et al.  Shared and Unique Determinants of the Erythropoietin (EPO) Receptor Are Important for Binding EPO and EPO Mimetic Peptide* , 1999, The Journal of Biological Chemistry.

[20]  C. Lynch,et al.  A homolog of the fungal nuclear migration gene nudC is involved in normal and malignant human hematopoiesis. , 1999, Experimental hematology.

[21]  I. Wilson,et al.  Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. , 1999, Science.

[22]  Robert M. Stroud,et al.  Efficiency of signalling through cytokine receptors depends critically on receptor orientation , 1998, Nature.

[23]  M. Anger-Leroy,et al.  Human thrombopoietin structure-function relationships: identification of functionally important residues. , 1998, The Biochemical journal.

[24]  C. Begley,et al.  Thrombopoietin in vitro and in vivo. , 1998, Cytokines, cellular & molecular therapy.

[25]  F. D. de Sauvage,et al.  Hematopoietic Deficiencies in c‐mpl and TPO Knockout Mice , 1998, Stem cells.

[26]  D. Smith,et al.  Identification of a Ligand-binding Site on the Granulocyte Colony-stimulating Factor Receptor by Molecular Modeling and Mutagenesis* , 1997, The Journal of Biological Chemistry.

[27]  L. Rangell,et al.  Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. , 1997, Blood.

[28]  L. Presta,et al.  Mutational Analysis of Thrombopoietin for Identification of Receptor and Neutralizing Antibody Sites* , 1997, The Journal of Biological Chemistry.

[29]  A. Haman,et al.  Crucial Role of the Residue R280 at the F′–G′ Loop of the Human Granulocyte/Macrophage Colony-stimulating Factor Receptor α Chain for Ligand Recognition , 1997, The Journal of experimental medicine.

[30]  C. Deane,et al.  A structural model of the human thrombopoietin receptor complex. , 1997, Journal of molecular graphics & modelling.

[31]  R. H. Gruninger,et al.  Identification of a Critical Ligand Binding Determinant of the Human Erythropoietin Receptor , 1996, The Journal of Biological Chemistry.

[32]  W S Alexander,et al.  Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. , 1996, Blood.

[33]  F. D. de Sauvage,et al.  Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin , 1996, The Journal of experimental medicine.

[34]  W. Alexander,et al.  Point mutations within a dimer interface homology domain of c‐Mpl induce constitutive receptor activity and tumorigenicity. , 1995, The EMBO journal.

[35]  W. Vainchenker,et al.  c-mpl, the Thrombopoietin Receptor , 1995, Thrombosis and Haemostasis.

[36]  W. Alexander,et al.  Structure and transcription of the genomic locus encoding murine c-Mpl, a receptor for thrombopoietin. , 1995, Oncogene.

[37]  C. M. Chen,et al.  The role of the WSXWS equivalent motif in growth hormone receptor function. , 1994, The Journal of biological chemistry.

[38]  A. Gurney,et al.  Thrombocytopenia in c-mpl-deficient mice. , 1994, Science.

[39]  K. Yasukawa,et al.  Structure‐function analysis of human IL‐6 receptor: dissociation of amino acid residues required for IL‐6‐binding and for IL‐6 signal transduction through gp130. , 1993, The EMBO journal.

[40]  D. Cosman.  The hematopoietin receptor superfamily. , 1993, Cytokine.

[41]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.